PHYCHEM TECHNOLOGIES LIMITED
About the company
Phychem Technologies Ltd. manufactures rotational molding (roto molding) compounds, essential for producing hollow plastic products. Its offerings include customized polyethylene-based compounds in powder or granule form for various industrial applications.
The company supplies to sectors like construction, agriculture, automotive, and consumer goods, providing specialty compounds such as flame-retardant, anti-static, foam, and stone-effect variants. It also offers custom-molded tanks and job work services like rotolining and toll pulverizing With an ISO 9001:2015 certified facility in Nashik, Maharashtra, Phychem exports to multiple countries and distributes imported products, including paints, polypropylene compounds, specialty release agents, and ancillary equipment for the roto molding industry.
Phychem Technologies demonstrated sustained growth across all key parameters from FY24 to FY26, with Total Revenue increasing from ₹46.97 Crs to ₹56.47 Crs and Profit After Tax more than doubling from ₹1.69 Crs to ₹4.09 Crs. Operational efficiency improved substantially as EBITDA margins expanded from 5.90% to 10.80%, driving a steady rise in EPS from ₹2.25 to ₹5.42. Reflecting this consistent performance, the company doubled its capital base, increasing Shareholders' Funds from ₹6.86 Crs to ₹13.79 Crs over the period.
The promoters of the company are Umakant Savadekar, Ulka Umakant Savadekar, Nivrutti Sonu Savdekar, and Vijaya Nivrutti Savdekar, collectively holding 90% of the pre-issue equity. Umakant Savadekar serves as Chairman and MD, while Ulka Savadekar is Whole-Time Director and CFO; Nivrutti and Vijaya Savdekar are Non-executive Directors. Except for their partnership in M/s Alkemy India, the promoters are not involved in any other business ventures.
Phychem Technologies Ltd is making fresh issue of up to 27,00,000 shares having face value of Rs 10 each aggregating Rs 15 Crs. The net offer to the public is 25,62,000 shares within the price band of Rs 51-54 per share. 9,00,000 shares offered to retail, while 3,86,000 shares offered to the Non-Institutional HNI category, 12,76,000 shares to QIBs, 7,68,000 shares to Anchor investors, & 1,38,000 shares will be reserved for Market Maker to the issue.
The shares will be listed on the BSE SME platform of the Bombay Stock Exchange (BSE).
Key metrics
Subscription status by category
Strengths & risks
Strengths / Operational Highlights
Phychem Technologies Ltd – Promoter-Led Management Driving Growth
Strong Promoter-Led Management Driving Growth: The company’s growth is guided by its experienced promoter team, led by Umakant Savadekar (Chairman & MD) and Ulka Savadekar (CFO), who bring strategic vision and operational expertise. Non-executive directors Nivrutti and Vijaya Savdekar provide governance and oversight, ensuring balanced decision-making. Their significant shareholding aligns their interests with long-term value creation and operational expansion.
Integrated Manufacturing and Distribution Model Ensuring Operational Control and Cost Efficiency – Phychem Technologies operates an integrated business model, manufacturing customized roto-molding compounds, providing job work services, and distributing specialized chemicals and equipment for the rotational molding industry. By controlling the entire value chain from formulation and quality-controlled production at its ISO-certified facility to exports and authorized distribution the company maintains operational efficiency, consistent product quality, and cost optimization. This model allows Phychem to cater to diverse industries while leveraging scale, in-house expertise, and strategic partnerships for enhanced profitability.
Diversified Product and Market Strategy Driving Growth: Phychem Technologies focuses on offering a wide range of customized roto-molding compounds and services, catering to multiple industries to minimize customer concentration and seasonal impact. Its in-house manufacturing facility ensures quality control, operational efficiency, and timely delivery. Growth is further supported by strong promoter-led management, long-standing customer relationships, and a diversified product portfolio across geographies.
Strategic Long-Term Growth Plan Focused on Product Expansion and Market Reach – Phychem Technologies aims to expand its product portfolio, including new nylon-based compounds, while continuing to offer customized and sustainable solutions. It focuses on reducing operating costs, improving efficiency, and leveraging economies of scale to enhance profitability. Additionally, it plans to grow its domestic and international customer base, strengthen market presence, and diversify geographically to drive long-term sustainable growth.
Risks
Phychem Technologies’s operations are highly dependent on its manufacturing facility, making it vulnerable to equipment breakdowns, industrial accidents, natural disasters, and regulatory disruptions. Labor-related issues, such as strikes or disputes, could also impact production and efficiency. Additionally, any significant delays or interruptions in manufacturing could adversely affect the company’s financial performance and operational continuity.
Financial snapshot
Anchor investor allocation
PROMINENT INSTITUTIONAL/DOMESTIC INVESTORS, INNOVATIVE VISION FUND, LRSD SECURITIES PVT.LTD., SB OPPORTUNITIES FUND II AND TATTVAM AIF TRUSTHAVE SUBSCRSIBED TO ANCHOR BOOK PHYCHEM TECHNOLOGIES LIMITED COMPANY'S 7,68,000 SHARES.
Strengths & risks
Strengths / Operational Highlights
Phychem Technologies Ltd – Promoter-Led Management Driving Growth
Strong Promoter-Led Management Driving Growth: The company’s growth is guided by its experienced promoter team, led by Umakant Savadekar (Chairman & MD) and Ulka Savadekar (CFO), who bring strategic vision and operational expertise. Non-executive directors Nivrutti and Vijaya Savdekar provide governance and oversight, ensuring balanced decision-making. Their significant shareholding aligns their interests with long-term value creation and operational expansion.
Integrated Manufacturing and Distribution Model Ensuring Operational Control and Cost Efficiency – Phychem Technologies operates an integrated business model, manufacturing customized roto-molding compounds, providing job work services, and distributing specialized chemicals and equipment for the rotational molding industry. By controlling the entire value chain from formulation and quality-controlled production at its ISO-certified facility to exports and authorized distribution the company maintains operational efficiency, consistent product quality, and cost optimization. This model allows Phychem to cater to diverse industries while leveraging scale, in-house expertise, and strategic partnerships for enhanced profitability.
Diversified Product and Market Strategy Driving Growth: Phychem Technologies focuses on offering a wide range of customized roto-molding compounds and services, catering to multiple industries to minimize customer concentration and seasonal impact. Its in-house manufacturing facility ensures quality control, operational efficiency, and timely delivery. Growth is further supported by strong promoter-led management, long-standing customer relationships, and a diversified product portfolio across geographies.
Strategic Long-Term Growth Plan Focused on Product Expansion and Market Reach – Phychem Technologies aims to expand its product portfolio, including new nylon-based compounds, while continuing to offer customized and sustainable solutions. It focuses on reducing operating costs, improving efficiency, and leveraging economies of scale to enhance profitability. Additionally, it plans to grow its domestic and international customer base, strengthen market presence, and diversify geographically to drive long-term sustainable growth.
Risks
Phychem Technologies’s operations are highly dependent on its manufacturing facility, making it vulnerable to equipment breakdowns, industrial accidents, natural disasters, and regulatory disruptions. Labor-related issues, such as strikes or disputes, could also impact production and efficiency. Additionally, any significant delays or interruptions in manufacturing could adversely affect the company’s financial performance and operational continuity.
Our verdict
Our View on This IPO
Phychem Technologies Limited which is tapping the capital market, enjoys a strong track record of ramping up its turnover in the last two years & building strong business relationships with its domestic customers which has helped it significantly scale up its operations.
Phychem Technologies operates an integrated business model, manufacturing customized roto-molding compounds, providing job work services, and distributing specialized chemicals and equipment for the rotational molding industry. By controlling the entire value chain from formulation and quality-controlled production at its ISO-certified facility to exports and authorized distribution the company maintains operational efficiency, consistent product quality, and cost optimization. This model allows Phychem to cater to diverse industries while leveraging scale, in-house expertise, and strategic partnerships for enhanced profitability.
Phychem Technologies focuses on offering a wide range of customized roto-molding compounds and services, catering to multiple industries to minimize customer concentration and seasonal impact. Its in-house manufacturing facility ensures quality control, operational efficiency, and timely delivery. Growth is further supported by strong promoter-led management, long-standing customer relationships, and a diversified product portfolio across geographies.
More importantly, Phychem Technologies Limited promoters have significant industry experience and have been instrumental in the company's consistent growth. The management team's combined expertise and experience are also a significant asset going ahead
After the proposed IPO, the company’s net worth will total Rs 28.37 crs crore as on date after the IPO, & post-IPO, the equity capital will stand at Rs 10.24 crore.
We are confident that Phychem Technologies Limited will deliver consistent performance and provide a good investment opportunity for investors with a long-term horizon.
Hence, we recommend SUBSCRIBE for long-term investment.
Disclaimer
This document is meant for the recipient only for use as intended and not for circulation. This document
should not be reproduced or copied or made available to others. Recipients may not receive this report at
the same time as other recipients. The information contained herein is from the public domain or sources are
believed to be reliable. While reasonable care has been taken to ensure that information given is at the
time believed to be fair and correct and opinions based thereupon are reasonable, due to the very nature of
research it cannot be warranted or represented that it is accurate or complete and it should not be relied
upon as such. In so far as this report includes current or historical information, it is believed to be
reliable, although its accuracy and completeness cannot be guaranteed. Opinions expressed are current
opinions as of the date appearing on this material only. While we endeavour to update on a reasonable basis,
the information discussed in this material, Mr Avinash Gorakshakar is under no obligation to update or keep
the information current. Further there may be regulatory, compliance, or other reasons that prevent me from
doing so. Prospective investors and others are cautioned that any forward-looking statements are not
predictions and may be subject to change without notice. Avinash Gorakshakar and any person connected with
it, will not in any way be responsible for the contents of this report or for any losses, costs, expenses,
charges, including notional losses/lost opportunities incurred by a recipient as a result of acting or
non-acting on any information/material contained in the report. This is not an offer to sell or a
solicitation to buy any securities or an attempt to influence the opinion or behaviour of investors or
recipients or provide any investment/tax advice. This report is for information only and has not been
prepared based on specific investment objectives. The securities discussed in this report may not be
suitable for all investors. Investors must make their own investment decision based on their own investment
objectives, goals and financial position and based on their own analysis. Trading in stocks, stock
derivatives, and other securities is inherently risky and the recipient agrees to assume complete and full
responsibility for the outcomes of all trading decisions that the recipient makes, including but not limited
to loss of capital. Opinions, projections and estimates in this report solely constitute the current
judgment of the author of this report as of the date of this report and do not in any way reflect the views
of Avinash Gorakshakar. The securities described herein may or may not be eligible for sale in all
jurisdictions or to certain category of investors. Persons in whose possession this document may come are
required to inform themselves of and to observe such restriction.
SEBI REGN NO. INH000001071